Skip to main content
Log in

Production of 5–15 µm Diameter Alginate-Polylysine Microcapsules by an Air-Atomization Technique

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

A novel method of preparing small-sized microcapsules using a Turbotak air-atomizer is reported. Alginate-polylysine microcapsules containing Bacillus Calmette Guérin vaccine have been prepared by an adaptation of the method of Lim (1) which allows the manufacture of small-sized microcapsules. A Turbotak is used to spray sodium alginate solution into calcium chloride solution to form temporary calcium alginate microgel capsules. These temporary microgel droplets are subsequently cross-linked with polylysine to form permanent membranes. Microcapules in the size range of 5–15 µm have been produced which can be compared to an average diameter of ≥300 µm obtained by the method reported by Lim. The microcapsule size is dependent on the conditions of operation of the Turbotak and the concentration of the sodium alginate solution. Particles within the size range 5–15 µm can be reproducibly manufactured using the conditions of operation reported here. Other size ranges below the minimum of 300 µm reported by Lim are also feasible using this technique.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. F. Lim and A. M. Sun. Microencapsulated islets as bioartificial endocrine pancreas. Science 210:908–910 (1980).

    Google Scholar 

  2. L. Illum and S. S. Davis. Targeting of drugs parenterally by use of microspheres. J. Parent. Sci. Tech. 36:242–248 (1982).

    Google Scholar 

  3. L. Illum, P. D. E. Jones, and S. S. Davis. Active targeting in-vivo and in-vitro—homing with antibodies and magnetic particles. In S. S. Davis, L. Illum, J. G. McVie, and E. Tomlinson (eds.), Microspheres and Drug Therapy, Elsevier, Amsterdam, 1984, pp. 353–363.

    Google Scholar 

  4. M. J. Groves, M. E. Klegerman, P. Devadoss, O. N. Singh, and Y. Zong. Characterization of BCG vaccine by Coulter counter and scanning electron microscopic techniques. Part. Part. Sys. Character. (in press).

  5. M. F. McKneally, C. Maver, H. W. Kausel, and R. D. Alby. Regional immunotherapy with intrapleural BCG for lung cancer: Surgical consideration. J. Thorac. Cardio. Surg. 72:333–338 (1976).

    Google Scholar 

  6. M. F. McKneally, C. Maver, and H. W. Kausel. Regional immunotherapy of lung cancer with intrapleural BCG. Lancet 1:377–379 (1976).

    Google Scholar 

  7. M. F. McKneally, C. Maver, and H. W. Kausel. Intrapleural BCG immunostimulation in lung cancer. Lancet 1:1003 (1977).

    Google Scholar 

  8. E. M. Hersh, J. U. Gutterman, and G. M. Mavligit. BCG as adjuvant immunotherapy for neoplasia. Annu. Rev. Med. 28:489–515 (1977).

    Google Scholar 

  9. B. Zbar, I. D. Berstein, and H. J. Rapp. Suppression of tumor growth at the site of injection with living BCG. J. Natl. Cancer Inst. 46:831–839 (1971).

    Google Scholar 

  10. C. Pinsky, Y. Hirshaut, and H. Oettgen. Treatment of malignant melanoma by intratumoral injection of BCG. Natl. Cancer Inst. Monogr. 39:225–228 (1973).

    Google Scholar 

  11. L. Nathanson. Regression of intradermal malignant melanoma after intralesional injection of BCG. Cancer Chemother. Rep. 56:659–665 (1972).

    Google Scholar 

  12. D. R. Kelley and W. J. Catalona. BCG therapy for superficial bladder cancer. In W. J. Catalona and T. L. Ratliff (eds.), Urologic Oncology, Martinus Nijhoff, Boston, 1984, pp. 169–184.

    Google Scholar 

  13. D. J. Burgess and J. E. Carless. Manufacture of gelatin/gelatin coacervate microcapsules. Int. J. Pharm. 27:61–70 (1987).

    Google Scholar 

  14. S. Benita, J. P. Benoit, F. Puisieux, and C. Thies. Characterization of drug-loaded poly (d,l-lactide) microspheres. J. Pharm. Sci. 73:1721–1724 (1984).

    Google Scholar 

  15. T. Sato, M. Kanke, H. Schroeder, and P. DeLuca. Porous biodegradable microspheres for controlled drug delivery. I. Assessment of processing conditions and solvent removal techniques. Pharm. Res. 5:21–30 (1988).

    Google Scholar 

  16. D. J. Burgess, S. S. Davis, and E. Tomlinson. Potential use of albumin microspheres as a drug delivery system. I. Preparation and in vitro release of steroids. Int. J. Pharm. 39:129–136 (1987).

    Google Scholar 

  17. D. J. Burgess, H. S. Kas, J. M. Kuk, and M. J. Groves. Alginate-polylysine microspheres containing living BCG vaccine for site specific delivery. Presented at the AAPS First National Meeting of the Biotechnology Section, Reno, Nevada, January 1988.

  18. K. K. Kwok, M. J. Groves, and D. J. Burgess. Sterile microencapsulation of BCG in alginate-poly-1-lysine by an air spraying technique. Proceedings of the 16th International Symposium on Controlled Release of Bioactive Materials, Chicago, August 1989, pp. 342–343.

  19. T. Allen, Particle Size Measurement, 3rd ed., Chapman and Hall, New York, 1981.

    Google Scholar 

  20. G. Herdan. Small Particle Statistics, 2nd ed., Butterworths, London, 1960.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kwok, K.K., Groves, M.J. & Burgess, D.J. Production of 5–15 µm Diameter Alginate-Polylysine Microcapsules by an Air-Atomization Technique. Pharm Res 8, 341–344 (1991). https://doi.org/10.1023/A:1015841531372

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015841531372

Navigation